4565.T
4565.T
JP3431300007
NXERA PHARMA CO LTD
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 29.615.000.000 28.835.000.000
2.7%
Cost of Revenue 8.198.000.000 7.616.000.000
7.6%
Gross Profit 21.418.000.000 21.219.000.000
0.9%
29.880.000.000 26.642.000.000
12.2%
Operating Income -8.462.000.000 -5.423.000.000
56.0%
Pretax Income -14.950.000.000 -4.662.000.000
220.7%
Net Income Common Stockholders -12.530.000.000 -4.838.000.000
159.0%
-- --
--
-- --
--
ende